Cargando…
Severe paradoxical disease activation following alemtuzumab treatment for multiple sclerosis
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7309519/ https://www.ncbi.nlm.nih.gov/pubmed/32522766 http://dx.doi.org/10.1212/NXI.0000000000000799 |
| _version_ | 1783549223719927808 |
|---|---|
| author | Brannigan, Jamie Jones, Joanne L. Stacpoole, Sybil R. L. |
| author_facet | Brannigan, Jamie Jones, Joanne L. Stacpoole, Sybil R. L. |
| author_sort | Brannigan, Jamie |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7309519 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-73095192020-07-06 Severe paradoxical disease activation following alemtuzumab treatment for multiple sclerosis Brannigan, Jamie Jones, Joanne L. Stacpoole, Sybil R. L. Neurol Neuroimmunol Neuroinflamm Clinical/Scientific Notes Lippincott Williams & Wilkins 2020-06-10 /pmc/articles/PMC7309519/ /pubmed/32522766 http://dx.doi.org/10.1212/NXI.0000000000000799 Text en Copyright © 2020 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology. This is an open access article distributed under the terms of the Creative Commons Attribution License 4.0 (CC BY) (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Clinical/Scientific Notes Brannigan, Jamie Jones, Joanne L. Stacpoole, Sybil R. L. Severe paradoxical disease activation following alemtuzumab treatment for multiple sclerosis |
| title | Severe paradoxical disease activation following alemtuzumab treatment for multiple sclerosis |
| title_full | Severe paradoxical disease activation following alemtuzumab treatment for multiple sclerosis |
| title_fullStr | Severe paradoxical disease activation following alemtuzumab treatment for multiple sclerosis |
| title_full_unstemmed | Severe paradoxical disease activation following alemtuzumab treatment for multiple sclerosis |
| title_short | Severe paradoxical disease activation following alemtuzumab treatment for multiple sclerosis |
| title_sort | severe paradoxical disease activation following alemtuzumab treatment for multiple sclerosis |
| topic | Clinical/Scientific Notes |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7309519/ https://www.ncbi.nlm.nih.gov/pubmed/32522766 http://dx.doi.org/10.1212/NXI.0000000000000799 |
| work_keys_str_mv | AT branniganjamie severeparadoxicaldiseaseactivationfollowingalemtuzumabtreatmentformultiplesclerosis AT jonesjoannel severeparadoxicaldiseaseactivationfollowingalemtuzumabtreatmentformultiplesclerosis AT stacpoolesybilrl severeparadoxicaldiseaseactivationfollowingalemtuzumabtreatmentformultiplesclerosis |